- IN₹55.51m
- IN₹41.13m
- IN₹164.95m
- 10
- 42
- 37
- 16
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.31 | ||
| Price to Tang. Book | 1.31 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.38 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -40.84% | ||
| Return on Equity | -27.13% | ||
| Operating Margin | -11.79% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | 222.31 | 164.95 | n/a | n/a | -25.8% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Brawn Biotech Limited is an India-based integrated healthcare company. The Company's pharmaceutical products cover all product segments, such as Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, And Nutritionals. Its products include Sefix-400 Capsules, Sefix-200 Capsules, Celevran Cream W/C (25GM), Voltran Gel W/C (25GM), Folic Acid Tablets 8P 5MG, Ponstran Capsules 250MG, Fugeran Cream W/C (15GM), Stopin Tablets, Cefixime Tablets 100MG (1*10), Cefixime Tablets USP 200MG (1*10), Carbramazepine 200 MG IP Tab, Potassium Chloride for Injection 15% 150mg/ml USP (10 ML), Promethazine HCL Injection 25 MG/ML, Allopurinol 100mg IP Tab, Carbamazepine 100 mg IP Tab, Feme Tab, Bromex Liquid, Salbutamol 4 mg IP Tab, Chlorpheniramine Maleate 4mg Tab, Pheniramine Maleate 25mg Tab, Eracef 500 mg, Erazide 1 Gm Injection, Hyoscine Butyl Bromide (1 ml) IP Inj, Alprazolam 0.5 Mg Tab, and others.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 7th, 1985
- Public Since
- March 6th, 1995
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange- Shares in Issue
- 3,000,300
- Address
- C-64, Lajpat Nagar - 1, NEW DELHI, 110024
- Web
- https://brawnbiotech.com/
- Phone
- +91 1129815331
- Auditors
- M/s. Rajiv Udai & Associates
Upcoming Events for 530207
Q1 2026 Brawn Biotech Ltd Earnings Release
Brawn Biotech Ltd Annual Shareholders Meeting
Similar to 530207
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Brawn Biotech share price?
As of Today at 19:41 UTC, shares in Brawn Biotech are trading at IN₹18.50. This share price information is delayed by 15 minutes.
How has the Brawn Biotech share price performed this year?
Shares in Brawn Biotech last closed at IN₹18.50 and the price had moved by -13.79% over the past 365 days. In terms of relative price strength the Brawn Biotech share price has underperformed the S&P BSE 100 Index by -18.79% over the past year.
What are the analyst and broker recommendations for Brawn Biotech?
There is no consensus recommendation for this security.
Find out moreWhat is the Brawn Biotech dividend yield?
Brawn Biotech does not currently pay a dividend.
Does Brawn Biotech pay a dividend?
Brawn Biotech does not currently pay a dividend.
When does Brawn Biotech next pay dividends?
Brawn Biotech does not currently pay a dividend.
How do I buy Brawn Biotech shares?
To buy shares in Brawn Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Brawn Biotech?
As of the previous close price of IN₹18.50, shares in Brawn Biotech had a market capitalisation of IN₹55.51m.
Where are Brawn Biotech shares listed?
Here are the trading details for Brawn Biotech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 530207
What kind of share is Brawn Biotech?
Based on an overall assessment of its quality, value and momentum Brawn Biotech is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Brawn Biotech share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Brawn Biotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Brawn Biotech. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -0.57%.
As of the last closing price of IN₹18.50, shares in Brawn Biotech were trading -10.17% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Brawn Biotech PE Ratio?
The Brawn Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹18.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Brawn Biotech?
We do not have data on Brawn Biotech's directors